ABA and AFFI met with FDA to discuss industry’s concerns on pending FSMA proposals including preventive controls, foreign supplier verification and third party certification. ABA specifically reinforced our support for the warehouse/depot exemption and the rationale for ABA’s petition which was the basis for the language FDA included in its preventive control proposal.